The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment

The Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision; clinical application of results of a randomized trial:diabetic retinopathy vitrectomy study report 4. Ophthalmology 95(10):1321–1334. https://doi.org/10.1016/s0161-6420(88)33014-9

Article  Google Scholar 

La Heij EC, Tecim S, Kessels AG, Liem AT, Japing WJ, Hendrikse F (2004) Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 242:210–217

Article  PubMed  Google Scholar 

Meleth AD, Carvounis PE (2014) Outcomes of vitrectomy for tractional retinal detachment in diabetic retinopathy. Int Ophthalmol Clin 54(2):127–139

Article  PubMed  Google Scholar 

McCullough P, Mohite A, Virgili G, Lois N (2023) Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 141(2):186–195. https://doi.org/10.1001/jamaophthalmol.2022.5817

Article  PubMed  PubMed Central  Google Scholar 

Al-Khersan H, Venincasa MJ, Kloosterboer A, Sridhar J, Smiddy WE, Townsend JH et al (2020) Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol (Auckland, NZ) 14:1559–1563. https://doi.org/10.2147/opth.s252285

Article  Google Scholar 

Gupta B, Wong R, Sivaprasad S, Williamson TH (2012) Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye (London, England) 26(4):576–582. https://doi.org/10.1038/eye.2011.348

Article  CAS  PubMed  Google Scholar 

Farouk MM, Naito T, Sayed KM, Nagasawa T, Katome T, Radwan G et al (2011) Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 249(3):369–376. https://doi.org/10.1007/s00417-010-1506-7

Article  PubMed  Google Scholar 

Le Mer Y, Korobelnik JF, Morel C, Ullern M, Berrod JP (1999) TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial. Retina (Philadelphia, Pa) 19(5):378–382. https://doi.org/10.1097/00006982-199909000-00002

Article  PubMed  Google Scholar 

Ghasemi Falavarjani K, Modarres M, Hadavandkhani A, Karimi MA (2015) Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy. Eye 29(9):1199–1203. https://doi.org/10.1038/eye.2015.114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iglicki M, Zur D, Fung A, Gabrielle P-H, Lupidi M, Santos R et al (2019) Tractional diabetic retinal detachment surgery with co-adjuvant intravitreal dexamethasone implant: the tradition study. Acta Diabetol 56:1141–1147

Article  CAS  PubMed  Google Scholar 

Pratt WB (1994) The anticancer drugs. Oxford University Press, USA

Google Scholar 

Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT (1998) Antimetabolite-induced apoptosis in Tenon’s capsule fibroblasts. Investig Ophthalmol Vis Sci 39(2):449–454

CAS  Google Scholar 

Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz G, McGorray S (1993) Prolonged localized tissue effects from 5-minute exposures to fluorouracil and Mitomycin C. Arch Ophthalmol 111(2):263–267. https://doi.org/10.1001/archopht.1993.01090020117035

Article  CAS  PubMed  Google Scholar 

Assi A, Khoueir Z, Helou C, Fakhoury H, Cherfan G (2019) Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries. Eye 33(8):1261–1270

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gürelik G, Sül S, Üçgül AY (2021) Intraocular Mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments. Eur J Ophthalmol 31(6):3284–3293

Article  PubMed  Google Scholar 

Gurelik G, Korkmaz S, Uyar Gocun P, Sul S (2022) Evaluation the safety of a new intraocular Mitomycin C application technique in the rabbit. Ret-Vit 31(4):387–393. https://doi.org/10.37845/ret.vit.2022.31.66

Article  Google Scholar 

Garner A (1993) Histopathology of diabetic retinopathy in man. Eye 7(2):250–253

Article  PubMed  Google Scholar 

Pastor JC, Rojas J, Pastor-Idoate S, Di Lauro S, Gonzalez-Buendia L, Delgado-Tirado S (2016) Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 51:125–155

Article  PubMed  Google Scholar 

Mirshahi A, Lashay A, Mehrabi Bahar MR, Abrishami M (2018) Consequences of inadvertent intravitreal Mitomycin C injection. Int J Ret Vit 4(1):7. https://doi.org/10.1186/s40942-018-0110-6

Article  Google Scholar 

Gui F, You Z, Fu S, Wu H, Zhang Y (2020) endothelial dysfunction in diabetic retinopathy. Front Endocrinol 11:591. https://doi.org/10.3389/fendo.2020.00591

Article  Google Scholar 

Iyer SSR, Lagrew MK, Tillit SM, Roohipourmoallai R, Korntner S (2021) The vitreous ecosystem in diabetic retinopathy: insight into the patho-mechanisms of disease. Int J Mol Sci 22(13):7142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tamaki K, Usui-Ouchi A, Murakami A, Ebihara N (2016) Fibrocytes and fibrovascular membrane formation in proliferative diabetic retinopathy. Investig Ophthalmol Vis Sci 57(11):4999–5005. https://doi.org/10.1167/iovs.16-19798

Article  CAS  Google Scholar 

Roy S, Amin S, Roy S (2016) Retinal fibrosis in diabetic retinopathy. Exp Eye Res 142:71–75. https://doi.org/10.1016/j.exer.2015.04.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Wang S, Xia X (2012) Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37(5):416–420

Article  CAS  PubMed  Google Scholar 

Abdelhadi AM, Helaly HA, Abuelkeir A (2020) Evaluation of retinal detachment after diabetic vitrectomy: causes and ways of management. Clin Ophthalmol (Auckland, NZ) 14:53–60. https://doi.org/10.2147/opth.s235757

Article  CAS  Google Scholar 

Stewart MW, Browning DJ, Landers MB (2018) Current management of diabetic tractional retinal detachments. Indian J Ophthalmol 66(12):1751–1762. https://doi.org/10.4103/ijo.IJO_1217_18

Article  PubMed  PubMed Central  Google Scholar 

Yau GL, Silva PS, Arrigg PG, Sun JK (2018) Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol 33(1):126–133. https://doi.org/10.1080/08820538.2017.1353832

Article  PubMed  Google Scholar 

Jonas J, Söfker A, Degenring R (2003) Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 13(5):468–473

Article  CAS  PubMed  Google Scholar 

Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res Ther 4(4):1–8

Google Scholar 

Taylor SR, Habot-Wilner Z, Pacheco P, Lightman S (2012) Intravitreal methotrexate in uveitis. Ophthalmol 119(4):878–879. https://doi.org/10.1016/j.ophtha.2011.12.015

Article  Google Scholar 

留言 (0)

沒有登入
gif